PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
20117004-0	2010	Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors.	3-substituted indolin-2-one	75-102	ret proto-oncogene	Homo sapiens	103-106
31268308-0	2019	Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.	3-substituted indolin-2-one	29-56	mitogen-activated protein kinase 10	Homo sapiens	100-125
31268308-0	2019	Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.	3-substituted indolin-2-one	29-56	mitogen-activated protein kinase 10	Homo sapiens	127-131
31268308-3	2019	Herein, we report 3-substituted indolin-2-one derivatives as the first isoform-selective JNK3 inhibitors by multistage screening.	3-substituted indolin-2-one	18-45	mitogen-activated protein kinase 10	Homo sapiens	89-93